Randomness (r_ness) wrote,
Randomness
r_ness

I've been saying since the news first hit about Daraprim that the people who should be angriest about Martin Shkreli and his douchebaggery are the rest of the biotech industry. He painted a great big target on their backs.

From Barron's:
There’s blood in the streets, but nobody’s buying.

Biotechnology and pharmaceutical stocks lead the way down during Monday’s broad stock selloff. Endo International (ENDP), Regeneron (REGN) and Mylan (MYL) were among the worst decliners on the S&P 500, falling 10%, 7.5% and 6.3%, respectively.

Health care stocks on the S&P 500 declined 3.8%.

The horror show for the sector’s stocks began a week ago, after Hillary Clinton made overtures about controlling fast-rising drug costs. On Monday, selling accelerated after Democratic lawmakers distributed a letter calling for a subpoena to force Valeant Pharmaceuticals (VRX) to fork over more documents related to price increases for two heart drugs.

Valeant’s shares are listed in Canada, so the stock isn’t a constituent of big U.S. stock indexes. No matter. Concerns about Vertex fueled indiscriminate selling shares of drug makers on record trading volumes.
That asshole probably shorted all his competitors as soon as he started to feel the heat.

Disclaimer: I have no positions in any stocks mentioned and do not plan to initiate any in the next 72 hours.
Subscribe
  • Post a new comment

    Error

    default userpic

    Your reply will be screened

    Your IP address will be recorded 

    When you submit the form an invisible reCAPTCHA check will be performed.
    You must follow the Privacy Policy and Google Terms of use.
  • 1 comment